Ernesto Valero

Dr. Ernesto Valero


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
PPPatricia Palau
Patricia Palau
EDEloy Domínguez
Eloy Domínguez
LLLaura López-bueno
Laura López-bueno
JRJosé María Ramón
José María Ramón
RHRaquel Heredia
Raquel Heredia
JNJulio Núñez
Julio Núñez

25 July 2018 in Biomarkers in Medicine
Verified
Journal Article
Closed access
JGJessika González-D’gRegorio
Jessika González-D’gRegorio
GMGema Miñana
Gema Miñana
JNJulio Núñez
Julio Núñez
ENEduardo Núñez
Eduardo Núñez
VRVicente Ruiz
Vicente Ruiz
JSJuan Sanchis
Juan Sanchis
Aim: We evaluated the relationship between iron deficiency (ID) and long-term mortality risk in elderly patients with acute coronary syndrome (ACS). Methods: In this prospective observational study, we included 252 patients older than 65 years with ACS. Transferrin saturation (TSAT) and ferritin were collected before discharge. Results: Mean age, hemoglobin and GRACE score were 78 ± 7 years, 12.4 ± 1.8 g/dl and 138.8 ± 25.3, respectively, 112(44.4%) patients were women, and 151(59.9%) presented ID. During the follow-up, 121 (48%) patients died. Mortality rates among TSAT quartiles were: 2.38, 1.60, 0.90 and 0.95 × 10 person-years for Q1TSAT to Q4TSAT, respectively (p < 0.001) and did not differ across ferritin quartiles (p = 0.601), whereas ID definition was borderline associated (p = 0.060). Adjusted TSAT levels remained inverse, nonlinearly associated with long-term mortality risk (p < 0.001), with an exponential increased-risk from values about 20% and below. Conclusion: Lower TSAT levels were independ...

1 March 2021 in The American Journal of Medicine
Verified
Journal Article
Closed access
JSJuan Sanchis
Juan Sanchis
CSClara Sastre
Clara Sastre
Mª Arántzazu Ruescas NicolauMª Arántzazu Ruescas Nicolau
Mª Arántzazu Ruescas Nicolau
VRVicente Ruiz
Vicente Ruiz
EVErnesto Valero
Ernesto Valero
JNJulio Núñez
Julio Núñez

1 January 2018 in EuroIntervention
Verified
Journal Article
Closed access
EVErnesto Valero
Ernesto Valero
LCLuciano Consuegra-Sánchez
Luciano Consuegra-Sánchez
GMGema Miñana
Gema Miñana
SGSergio García-Blas
Sergio García-Blas
JRJuan Rodríguez
Juan Rodríguez
JNJulio Núñez
Julio Núñez
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

1 September 2019 in International Journal of Cardiology
Verified
Journal Article
Closed access
RERafael De la Espriella
Rafael De la Espriella
ESEnrique Santas
Enrique Santas
FCFrancisco J Chorro
Francisco J Chorro
GMGema Miñana
Gema Miñana
MSMeritxell Soler
Meritxell Soler
JNJulio Núñez
Julio Núñez

21 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SGSergio García-Blas
Sergio García-Blas
Clara BonanadClara Bonanad
Clara Bonanad
AFAgustín Fernández-Cisnal
Agustín Fernández-Cisnal
CSClara Sastre-Arbona
Clara Sastre-Arbona
Mª Arántzazu Ruescas NicolauMª Arántzazu Ruescas Nicolau
Mª Arántzazu Ruescas Nicolau
JSJuan Sanchis
Juan Sanchis
We aimed to compare the prognostic value of two different measures, the Fried’s Frailty Scale (FFS) and the Clinical Frailty Scale (CFS), following myocardial infarction (MI). We included 150 patients ≥ 70 years admitted from AMI. Frailty was evaluated on the day before discharge. The primary endpoint was number of days alive and out of hospital (DAOH) during the first 800 days. Secondary endpoints were mortality and a composite of mortality and reinfarction. Frailty was diagnosed in 58% and 34% of patients using the FFS and CFS scales, respectively. During the first 800 days 34 deaths and 137 admissions occurred. The number of DAOH decreased significantly with increasing scores of both FFS (p < 0.001) and CFS (p = 0.049). In multivariate analysis, only the highest scores (FFS = 5, CFS ≥ 6) were independently associated with fewer DAOH. At a median follow-up of 946 days, frailty assessed both by FFS and CFS was independently associated with death and MI (HR = 2.70 95%CI = 1.32–5.51 p = 0.001; HR = 2.01 95%CI = 1.1–3.66 p = 0.023, respectively), whereas all-cause mortality was only associated with FFS (HR = 1.51 95%CI = 1.08–2.10 p = 0.015). Frailty by FFS or CFS is independently associated with shorter number DAOH post-MI. Likewise, frailty assessed by either scale is associated with a higher rate of death and reinfarction, whereas FFS outperforms CFS for mortality prediction.